Menu
GeneBe

6-42964464-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000287.4(PEX6):​c.2814G>A​(p.Glu938=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.524 in 1,612,222 control chromosomes in the GnomAD database, including 227,508 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 24877 hom., cov: 33)
Exomes 𝑓: 0.52 ( 202631 hom. )

Consequence

PEX6
NM_000287.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.520
Variant links:
Genes affected
PEX6 (HGNC:8859): (peroxisomal biogenesis factor 6) This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) family of ATPases. This member is a predominantly cytoplasmic protein, which plays a direct role in peroxisomal protein import and is required for PTS1 (peroxisomal targeting signal 1, a C-terminal tripeptide of the sequence ser-lys-leu) receptor activity. Mutations in this gene cause peroxisome biogenesis disorders of complementation group 4 and complementation group 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 6-42964464-C-T is Benign according to our data. Variant chr6-42964464-C-T is described in ClinVar as [Benign]. Clinvar id is 92786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-42964464-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.52 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.725 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PEX6NM_000287.4 linkuse as main transcriptc.2814G>A p.Glu938= synonymous_variant 17/17 ENST00000304611.13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PEX6ENST00000304611.13 linkuse as main transcriptc.2814G>A p.Glu938= synonymous_variant 17/171 NM_000287.4 P1Q13608-1
PEX6ENST00000244546.4 linkuse as main transcriptc.*350G>A 3_prime_UTR_variant 15/151 Q13608-2

Frequencies

GnomAD3 genomes
AF:
0.558
AC:
84663
AN:
151794
Hom.:
24839
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.732
Gnomad AMI
AF:
0.671
Gnomad AMR
AF:
0.419
Gnomad ASJ
AF:
0.465
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.491
Gnomad FIN
AF:
0.462
Gnomad MID
AF:
0.506
Gnomad NFE
AF:
0.535
Gnomad OTH
AF:
0.551
GnomAD3 exomes
AF:
0.476
AC:
118313
AN:
248410
Hom.:
30370
AF XY:
0.484
AC XY:
65166
AN XY:
134716
show subpopulations
Gnomad AFR exome
AF:
0.735
Gnomad AMR exome
AF:
0.312
Gnomad ASJ exome
AF:
0.468
Gnomad EAS exome
AF:
0.194
Gnomad SAS exome
AF:
0.512
Gnomad FIN exome
AF:
0.456
Gnomad NFE exome
AF:
0.530
Gnomad OTH exome
AF:
0.501
GnomAD4 exome
AF:
0.520
AC:
760079
AN:
1460310
Hom.:
202631
Cov.:
50
AF XY:
0.521
AC XY:
378761
AN XY:
726500
show subpopulations
Gnomad4 AFR exome
AF:
0.738
Gnomad4 AMR exome
AF:
0.330
Gnomad4 ASJ exome
AF:
0.466
Gnomad4 EAS exome
AF:
0.205
Gnomad4 SAS exome
AF:
0.522
Gnomad4 FIN exome
AF:
0.454
Gnomad4 NFE exome
AF:
0.537
Gnomad4 OTH exome
AF:
0.515
GnomAD4 genome
AF:
0.558
AC:
84754
AN:
151912
Hom.:
24877
Cov.:
33
AF XY:
0.549
AC XY:
40736
AN XY:
74238
show subpopulations
Gnomad4 AFR
AF:
0.732
Gnomad4 AMR
AF:
0.418
Gnomad4 ASJ
AF:
0.465
Gnomad4 EAS
AF:
0.182
Gnomad4 SAS
AF:
0.491
Gnomad4 FIN
AF:
0.462
Gnomad4 NFE
AF:
0.535
Gnomad4 OTH
AF:
0.547
Alfa
AF:
0.548
Hom.:
11623
Bravo
AF:
0.562
Asia WGS
AF:
0.353
AC:
1231
AN:
3478
EpiCase
AF:
0.539
EpiControl
AF:
0.537

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicOct 21, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 13, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 10, 2016Variant summary: The PEX6 c.2814G>A (p.Glu938Glu) variant causes a synonymous change involving a non-conserved nucleotide with 5/5 splice prediction tools predict no significant impact on normal splicing and ESE finder predicts that this variant may alter ESE binding. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 58981/120096 (15519 homozygotes, 1/2), which significantly exceeds the estimated maximal expected allele frequency for a pathogenic PEX6 variant of 1/516 (0.0019365), suggesting this variant is likely a benign polymorphism. In addition, multiple reputable clinical diagnostic laboratories/databases cite the variant as "benign." Therefore, the variant of interest has been classified as Benign. -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 25, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Peroxisome biogenesis disorder 4A (Zellweger) Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Heimler syndrome 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Zellweger spectrum disorders Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Peroxisome biogenesis disorder Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Peroxisome biogenesis disorder 4B Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
6.3
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1129186; hg19: chr6-42932202; COSMIC: COSV55103195; COSMIC: COSV55103195; API